跳至主要内容
临床试验/NCT01470573
NCT01470573已完成2 期

Regenerative Medicine in Ocular Surface: Application of Cell Therapy for Ocular Surface Repair Using Progenitor Autologous Cells of Sclerocorneal Limbus Amplified ex Vivo

Fundacion Clinic per a la Recerca Biomédica6 个研究点 分布在 1 个国家目标入组 10 人开始时间: 2011年11月1日最近更新:
适应症

试验速览

阶段
2 期
状态
已完成
发起方
入组人数
10
试验地点
6
主要终点
Visual Acuity

研究概览

简要总结

Progenitor limbo sclerocorneal cells have properties of proliferation and differentiation to corneal and conjunctival epithelium. This cells can be isolated and ex vivo expanded using cell culture technics that could permit the biological replacement of damaged ocular surface.

研究设计

研究类型
Interventional
分配方式
Na
干预模型
Single Group
主要目的
Treatment
盲法
None

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • principal Inclusion Criteria:
  • Serious unilateral limbic insufficiency
  • Normal ophthalmological clinical examination in the opposite eye (biopsied eye)

排除标准

  • serious disorders in palpebral dynamics
  • bilateral limbic insufficiency, immunological, systemic or local illness like toxical epidermic necrosis or pemphigoid
  • breastfeeding or pregnancy
  • positive serology of HIV, VLTH, HVC, HVB, CMV, Trypanosoma Cruzi or Treponema Pallidum

结局指标

主要结局

Visual Acuity

时间窗: 6 months

visual acuity improvement

次要结局

  • Improvement in appearance of ocular surface(6 months)
  • lack of scar tissue in ocular surface(6 months)
  • decrease of preexisting corneal vascularization(6 months)
  • Improvement of corneal transparency(6 months)
  • absence or decrease of corneal conjunctivalization(6 months)
  • adverse events(6 months)

研究者

发起方
Fundacion Clinic per a la Recerca Biomédica
申办方类型
Other
责任方
Principal Investigator
主要研究者

Sara Varea

Clinical Research Manager

Fundacion Clinic per a la Recerca Biomédica

研究点 (6)

Loading locations...

相似试验